Clinical Performance of 59% Hioxifilcon A vs. Marketed Hydrogel Contact Lenses in Habitual Hydrogel Wearers
NCT ID: NCT04986644
Last Updated: 2021-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2021-05-10
2021-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Clinical Performance of 59% Hioxifilcon A Contact Lenses vs. Marketed Hydrogel Contact Lenses
NCT04671108
Clinical Evaluation Of Two Daily Disposable Contact Lenses And A Monthly Replacement Lens
NCT01151371
Clinical Evaluation of Daily Disposable Contact Lenses
NCT02097030
Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses
NCT01966770
Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical Study
NCT02637804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome variable for this study is overall subjective comfort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test to Moist
1 week of Test DD contact lenses followed by cross over to 1 week of 1-DAY ACUVUE® Moist contact lenses.
Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)
Daily disposable contact lens wear for 1 week
Moist to Test
1 week of 1-DAY ACUVUE® Moist contact lenses followed by cross over to 1 week of Test DD contact lenses.
Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)
Daily disposable contact lens wear for 1 week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)
Daily disposable contact lens wear for 1 week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vision correctable to 20/30 acuity in each eye with spherical DD contact lenses
* No ocular or systemic disease that contra-indicates soft contact lens wear
Exclusion Criteria
* Currently wearing 1-DAY ACUVUE® MOIST (comparator) contact lenses
* Currently using rewetting drops with habitual contact lenses
* Vision not correctable to 20/30
* Participating in another clinical trial
18 Years
42 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vision Service Plan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ross Eyecare
Atlanta, Georgia, United States
Professional VisionCare
Westerville, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VS-21-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.